FdaApplication
ANDA 217455
Identifiers
- fda_app_no: ANDA217455
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2023-05-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REGADENOSON | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION;INTRAVENOUS |
1 product